Evidence map›Paper›PMID 35117031›Full record

ArticleTranslational cancer research2019

Analysis of volatile organic compounds released from SW480 colorectal cancer cells and the blood of tumor-bearing mice.

Desheng Liu, Linlin Ji, Mingjuan Li, Dandan Li, Lei Guo, Maomao Nie, Dongchun Wang, Yang Lv, Yang Bai, Miao Liu and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Translational cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Effect of HScientific reports · 2025
    Article
  4. Article
  5. Article
  6. Urinary VOCs as biomarkers of early stage lung tumour development in mice.Cancer biomarkers : section A of Disease markers · 2024
    Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Desheng Liu *Department of Anesthesiology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Linlin Ji *Department of Anesthesiology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Mingjuan LiDepartment of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao 266000, China.
Dandan LiDepartment of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Lei GuoDepartment of Anesthesiology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Maomao NieDepartment of Anesthesiology, Laishan Branch of Yantai Yuhuangding Hospital, Yantai 264003, China.
Dongchun WangDepartment of Anesthesiology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Yang LvDepartment of Anesthesiology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Yang BaiDepartment of Anesthesiology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Miao LiuDepartment of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Guiyue WangDepartment of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Yuhang LiDepartment of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Pulin YuDepartment of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Enyou LiDepartment of Anesthesiology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Changsong WangDepartment of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Harbin Medical University · CNThird Affiliated Hospital of Harbin Medical University · CNFirst Affiliated Hospital of Harbin Medical University · CNWenzhou Medical University · CNAffiliated Hospital of Qingdao University · CNYuhuangding Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVolatile organic compound (VOC) analysis provides an elegant approach for colorectal cancer screening. An organic compound with a high vapor pressure or volatility can be detected in the headspace of cancer cells or blood samples. Therefore, analyzing VOCs in the blood of rats inoculated with colorectal cancer tissue and in SW480 medium from cultured colorectal cancer cells may provide accurate results.

methodsAfter collecting venous blood from rats inoculated with cancer cells at different times, the cancer tissue was removed from the inoculated rats, and the medium was harvested from the cancer cells and cultured in the presence or absence of a chemotherapy drug of intestinal epithelial cells. We used solid-phase microextraction-gas chromatography-mass spectrometry (SPME-GC-MS) to analyze the headspace of the blood and media to evaluate the VOC profiles. Statistical analysis was conducted using principal component analysis (PCA) and orthogonal partial least-squares analysis (OP-LSDA).

resultsThe

conclusionsBy analyzing VOC fingerprints related to colorectal cancer (CRC), we found that butylated hydroxytoluene and acetone have unique signatures that may provide the basis for clinical diagnosis and disease assessment.

Indexed as

Acetonebiomarkersbutylated hydroxytoluenecolorectal cancer (CRC)volatile organic compound

Identifiers

PMID35117031
PMCPMC8797338
OpenAlexW2997926102

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.